144 related articles for article (PubMed ID: 32265034)
1. Pyk2 downstream of G
Chaudhary PK; Han JS; Jee Y; Lee SH; Kim S
Biochem Biophys Res Commun; 2020 Jun; 526(3):738-743. PubMed ID: 32265034
[TBL] [Abstract][Full Text] [Related]
2. Distinct role of Pyk2 in mediating thromboxane generation downstream of both G12/13 and integrin αIIbβ3 in platelets.
Kim S; Cipolla L; Guidetti G; Okigaki M; Jin J; Torti M; Kunapuli SP
J Biol Chem; 2013 Jun; 288(25):18194-203. PubMed ID: 23640884
[TBL] [Abstract][Full Text] [Related]
3. Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion.
Huang JS; Dong L; Kozasa T; Le Breton GC
J Biol Chem; 2007 Apr; 282(14):10210-22. PubMed ID: 17298951
[TBL] [Abstract][Full Text] [Related]
4. The frog trefoil factor Bm-TFF2 activates human platelets via Gq and G12/13 signaling pathway.
Lei W; Huang Y; Zhang Y; Yu G; Wan S; Lee W; Zhang Y
Toxicon; 2012 Jan; 59(1):104-9. PubMed ID: 22100826
[TBL] [Abstract][Full Text] [Related]
5. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets.
Klages B; Brandt U; Simon MI; Schultz G; Offermanns S
J Cell Biol; 1999 Feb; 144(4):745-54. PubMed ID: 10037795
[TBL] [Abstract][Full Text] [Related]
6. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
Dorsam RT; Kim S; Jin J; Kunapuli SP
J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512
[TBL] [Abstract][Full Text] [Related]
7. Trypsin causes platelet activation independently of known protease-activated receptors.
Mao Y; Kunapuli SP
Thromb Haemost; 2013 Dec; 110(6):1241-9. PubMed ID: 24030758
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase.
Kim S; Kunapuli SP
J Biol Chem; 2011 Jul; 286(27):24170-9. PubMed ID: 21592972
[TBL] [Abstract][Full Text] [Related]
9. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
10. PAK Membrane Translocation and Phosphorylation Regulate Platelet Aggregation Downstream of Gi and G12/13 Pathways.
Zhang J; Zhang Y; Zheng S; Liu Y; Chang L; Pan G; Hu L; Zhang S; Liu J; Kim S; Dong J; Ding Z
Thromb Haemost; 2020 Nov; 120(11):1536-1547. PubMed ID: 32854120
[TBL] [Abstract][Full Text] [Related]
11. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
[TBL] [Abstract][Full Text] [Related]
12. Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility.
Carothers AM; Javid SH; Moran AE; Hunt DH; Redston M; Bertagnolli MM
Exp Cell Res; 2006 Feb; 312(4):387-400. PubMed ID: 16368433
[TBL] [Abstract][Full Text] [Related]
13. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis.
Yuan B; Cui J; Wang W; Deng K
Biochem Biophys Res Commun; 2016 May; 473(4):1240-1246. PubMed ID: 27084452
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new peptide agonist of the protease-activated receptor-1.
Mao Y; Jin J; Kunapuli SP
Biochem Pharmacol; 2008 Jan; 75(2):438-47. PubMed ID: 17950254
[TBL] [Abstract][Full Text] [Related]
15. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization.
Sonkar VK; Kulkarni PP; Dash D
FASEB J; 2014 Apr; 28(4):1819-29. PubMed ID: 24421399
[TBL] [Abstract][Full Text] [Related]
18. RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets.
Jin J; Mao Y; Thomas D; Kim S; Daniel JL; Kunapuli SP
Biochem Pharmacol; 2009 Mar; 77(5):835-44. PubMed ID: 19073150
[TBL] [Abstract][Full Text] [Related]
19. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation.
Ying Z; Giachini FR; Tostes RC; Webb RC
Cardiovasc Res; 2009 Jul; 83(1):155-62. PubMed ID: 19276129
[TBL] [Abstract][Full Text] [Related]
20. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
